Screening for Fabry Disease in a Pediatric Population at Risk
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02152189
Recruitment Status :
First Posted : June 2, 2014
Last Update Posted : December 13, 2017
University Hospital Heidelberg
Information provided by (Responsible Party):
Markus Ries, MD PhD MHSc FCP, University Hospital Heidelberg
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
up to 18 Years (Child, Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Children with rheumatological disorders or chronic abdominal pain
Age below 18 years
One of the following criteria:
Diagnosis or suspicion of a rheumatological disorder with recurrent complaints for more than 6 months
Chronic, recurrent abdominal pain for more than 6 months
Planned blood sample for routine diagnostics
Written informed consent
- Patient and/or the patient's parent(s) or legal guardian(s) are unable to understand the nature, scope, and possible consequences of the screening.